We are live on
!
Find out more
TP
Truvvo Partners Portfolio holdings
AUM
$5.22M
1-Year Est. Return
13.74%
This Fund
S&P 500
This Quarter
Est. Return
+3.95%
1 Year Est. Return
-13.74%
3 Year Est. Return
+21.12%
5 Year Est. Return
+59.28%
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$8.83M
(+5.8%)
Cap. Flow
+$3.97M
Cap. Flow
% of AUM
2.47%
Top 10 Holdings %
Top 10 Hldgs %
82.91%
Holding
52
New
1
Increased
6
Reduced
8
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$514K |
| 2 |
Mohawk Industries
MHK
|
+$193K |
| 3 |
Morgan Stanley
MS
|
+$193K |
| 4 |
Citigroup
C
|
+$168K |
| 5 |
Barclays
BCS
|
+$5.17K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immunic
IMUX
|
+$3.94M |
| 2 |
STDY
SteadyMed Ltd
STDY
|
+$1.68M |
| 3 |
SVU
SUPERVALU Inc.
SVU
|
+$851K |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$465K |
| 5 |
Bank of America
BAC
|
+$288K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 58.79% |
| 2 | Industrials | 5.39% |
| 3 | Communication Services | 3.99% |
| 4 | Healthcare | 3.46% |
| 5 | Consumer Discretionary | 2.12% |
Similar funds
TPMI
ARI
TSPM
GHIP
SIO
GPC
TPI
CCONH
Truvvo Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Truvvo Partners held 52 positions worth $161M, up 5.8% from $152M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Truvvo Partners's Q3 2018 filing shows 1 new, 6 increased, 8 reduced and 5 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,841 shares worth $467K. The largest sale was Immunic, an estimated $3.94M.
By sector, the portfolio is most concentrated in Financials at 59% of assets, down from 60% a quarter earlier, followed by Industrials and Communication Services.
- Truvvo Partners's largest Q3 2018 buy was Meta Platforms (Facebook): 2,841 shares worth $467K.
- Truvvo Partners added most to Mohawk Industries in Q3 2018, an estimated $193K increase.
- Truvvo Partners's biggest Q3 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $465K.
- Truvvo Partners fully exited Immunic in Q3 2018, selling an estimated $3.94M.
- Truvvo Partners's ten largest holdings make up 83% of its $161M portfolio in Q3 2018.
- Truvvo Partners opened 1 new position and closed 5 in Q3 2018.
- Truvvo Partners's portfolio value rose 5.8% quarter-over-quarter to $161M.
Based on Truvvo Partners's 13F filing for Q3 2018, filed 14 Nov 2018.